These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26508166)

  • 1. Unintentional extraction of a platinum-chromium everolimus-eluting stent by entanglement with a covered stent.
    Hagikura A; Goto K; Takebayashi H; Haruta S
    Eur Heart J; 2016 Apr; 37(13):1083. PubMed ID: 26508166
    [No Abstract]   [Full Text] [Related]  

  • 2. PLATINUM China: a prospective, randomized investigation of the platinum chromium everolimus-eluting stent in de novo coronary artery lesions.
    Gao R; Han Y; Yang Y; Zhang J; Hou Y; Wang H; Li H; Fang Q; Yu B; Xu B; Allocco DJ; Dawkins KD
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():716-23. PubMed ID: 25631909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trial.
    Kereiakes DJ; Cannon LA; Feldman RL; Popma JJ; Magorien R; Whitbourn R; Dauber IM; Rabinowitz AC; Ball MW; Bertolet B; Kabour A; Foster MC; Wang JC; Underwood P; Dawkins KD
    J Am Coll Cardiol; 2010 Jul; 56(4):264-71. PubMed ID: 20493653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses.
    Meredith IT; Whitbourn R; Scott D; El-Jack S; Zambahari R; Stone GW; Teirstein PS; Starzyk RM; Allocco DJ; Dawkins KD
    EuroIntervention; 2011 May; 7(1):84-90. PubMed ID: 21550907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delamination of novel ultrathin bioabsorbable abluminal polymer of platinum chromium everolimus-eluting stent.
    Fujimoto Y; Kobayashi Y; Kato K; Yamaguchi M
    Cardiovasc Interv Ther; 2018 Jan; 33(1):97-98. PubMed ID: 27848240
    [No Abstract]   [Full Text] [Related]  

  • 6. Three-year results comparing platinum-chromium PROMUS element and cobalt-chromium XIENCE V everolimus-eluting stents in de novo coronary artery narrowing (from the PLATINUM Trial).
    Meredith IT; Teirstein PS; Bouchard A; Carrié D; Möllmann H; Oldroyd KG; Hall J; Allocco DJ; Dawkins KD; Stone GW
    Am J Cardiol; 2014 Apr; 113(7):1117-23. PubMed ID: 24530167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.
    Ellis SG; Kereiakes DJ; Metzger DC; Caputo RP; Rizik DG; Teirstein PS; Litt MR; Kini A; Kabour A; Marx SO; Popma JJ; McGreevy R; Zhang Z; Simonton C; Stone GW;
    N Engl J Med; 2015 Nov; 373(20):1905-15. PubMed ID: 26457558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial.
    von Birgelen C; Sen H; Lam MK; Danse PW; Jessurun GA; Hautvast RW; van Houwelingen GK; Schramm AR; Gin RM; Louwerenburg JW; de Man FH; Stoel MG; Löwik MM; Linssen GC; Saïd SA; Nienhuis MB; Verhorst PM; Basalus MW; Doggen CJ; Tandjung K
    Lancet; 2014 Feb; 383(9915):413-23. PubMed ID: 24183564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention).
    Stefanini GG; Serruys PW; Silber S; Khattab AA; van Geuns RJ; Richardt G; Buszman PE; Kelbæk H; van Boven AJ; Hofma SH; Linke A; Klauss V; Wijns W; Macaya C; Garot P; Di Mario C; Manoharan G; Kornowski R; Ischinger T; Bartorelli AL; Gobbens P; Windecker S
    J Am Coll Cardiol; 2011 May; 57(22):2221-32. PubMed ID: 21616282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal compression of the platinum-chromium everolimus-eluting stent during coronary implantation: predisposing mechanical properties, incidence, and predictors in a large patient cohort.
    Leibundgut G; Gick M; Toma A; Valina C; Löffelhardt N; Büttner HJ; Neumann FJ
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):E206-14. PubMed ID: 22581708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Intravascular Ultrasound-Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial.
    Hong SJ; Kim BK; Shin DH; Nam CM; Kim JS; Ko YG; Choi D; Kang TS; Kang WC; Her AY; Kim YH; Hur SH; Hong BK; Kwon H; Jang Y; Hong MK;
    JAMA; 2015 Nov; 314(20):2155-63. PubMed ID: 26556051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strut tissue coverage and endothelial cell coverage: a comparison between bare metal stent platforms and platinum chromium stents with and without everolimus-eluting coating.
    Soucy NV; Feygin JM; Tunstall R; Casey MA; Pennington DE; Huibregtse BA; Barry JJ
    EuroIntervention; 2010 Nov; 6(5):630-7. PubMed ID: 21044918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).
    Maeng M; Baranauskas A; Christiansen EH; Kaltoft A; Holm NR; Krusell LR; Ravkilde J; Tilsted HH; Thayssen P; Jensen LO
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1161-7. PubMed ID: 25640050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
    Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
    Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delamination of abluminal polymer of biolimus-eluting stent.
    Fujimoto Y; Kobayashi Y; Yamaguchi M
    JACC Cardiovasc Interv; 2012 Mar; 5(3):e5-6. PubMed ID: 22440509
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravascular ultrasound guidance of multiple drug-eluting stent implantation in lesions associated with coronary aneurysms.
    Aleong G; Bañelos C; Alfonso F
    J Invasive Cardiol; 2009 May; 21(5):E77-80. PubMed ID: 19411730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions.
    Teirstein PS; Meredith IT; Feldman RL; Rabinowitz AC; Cannon LA; Lee TC; Dens J; Dubois CL; Mooney MR; Pompili VJ; Saito S; Allocco DJ; Dawkins KD; Stone GW
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):207-15. PubMed ID: 24905795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography imaging of everolimus-eluting bioresorbable vascular scaffold implanted into coronary vein graft at 3-month follow-up.
    Roleder T; Parma Z; Smolka G; Ochała A; Wojakowski W
    Eur Heart J; 2014 Sep; 35(33):2207. PubMed ID: 24722807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.